Patients and physicians can discuss costs of cancer treatment in the clinic

Journal of Oncology Practice

Volumn 11, Issue 4, 2015, Pages 308-312

  Kelly, Ronan J ^a   Forde, Patrick M ^a   Elnahal, Shereef M ^a   Forastiere, Arlene A ^a   Rosner, Gary L ^a   Smith, Thomas J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER THERAPY; COLORECTAL CANCER; CONSULTATION; CONVERSATION; DOCTOR PATIENT RELATION; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL INFORMATION; MOLECULARLY TARGETED THERAPY; ONCOLOGIST; PATIENT SATISFACTION; PHYSICIAN; PRACTICE GUIDELINE; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COST; ECONOMICS; EDUCATION; HEALTH PERSONNEL ATTITUDE; INTERPERSONAL COMMUNICATION; LUNG NEOPLASMS; MIDDLE AGED; ONCOLOGY; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COMMUNICATION; DEDUCTIBLES AND COINSURANCE; FEMALE; HEALTH CARE COSTS; HUMANS; LUNG NEOPLASMS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; MOLECULAR TARGETED THERAPY; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS;

EID: 84937687420     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2015.003780     Document Type: Article

References (22)

1. Mariotto AB, Yabroff KR, Shao Y, et al: Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103:117-28, 2011
2. Bach PB: Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med 360:626-633, 2009
3. Hillner BE, Smith TJ: Efficacy does not necessarily translate to cost effectiveness: A case study in the challenges associated with 21st-century cancer drug pricing. J Clin Oncol 27:2111-2113, 2009
4. Teno JM, Gozalo PL, Bynum JP, et al: Change in end-of-life care for Medicare beneficiaries: Site of death, place of care, and health care transitions in 2000, 2005, and 2009. JAMA 309:470-477, 2013
5. Shih YC, Ganz PA, Aberle D, et al: Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol 31:4151-4157, 2013
6. Ramsey S, Blough D, Kirchhoff A, et al: Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff 32:1143-1152, 2013
7. Wharam JF, Ross-Degnan D, Rosenthal MB: The ACA and high-deductible insurance-Strategies for sharpening a blunt instrument. N Engl J Med 369:1481-1484, 2013
8. Tilburt JC, Wynia MK, Sheeler RD, et al: Views of US physicians about controlling health care costs. JAMA 310:380-388, 2013
9. Schrag D, Hanger M: Medical oncologists' views on communicating with patients about chemotherapy costs: A pilot survey. J Clin Oncol 25:233-237, 2007
10. Holmes-Rovner M, Kroll J, Schmitt N, et al: Patient satisfaction with health care decisions: The satisfaction with decision scale. Med Dec 16:58-64, 1996
11. Tamburini M, Gangeri L, Brunelli C, et al: Assessment of hospitalised cancer patients' needs by the Needs Evaluation Questionnaire. Ann Oncol 11:31-37, 2000
12. Tamburini M, Gangeri L, Brunelli C, et al: Cancer patients' needs during hospitalisation: A quantitative and qualitative study. BMC Cancer 3:12, 2003
13. McDonagh JR, Elliott TB, Engelberg RA, et al: Family satisfaction with family conferences about end-of-life care in the intensive care unit: Increased proportion of family speech is associated with increased satisfaction. Crit Care Med 32:1484-1488, 2004
14. Hawkins NA, Ditto PH, Danks JH, et al: Micromanaging death: Process preferences, values, and goals in end-of-life medical decision making. Gerontologist 45:107-117, 2005
15. Halpern MT, Ward EM, Pavluck AL, et al: Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: A retrospective analysis. The Lancet Oncology 9:222-231, 2008
16. Ward E, Halpern M, Schrag N, et al: Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58:9-31, 2008
17. Meropol NJ, Schrag D, Smith TJ, et al: American Society of Clinical Oncology guidance statement: The cost of cancer care. J Clin Oncol 27:3868-3874, 2009
18. Ganz PA, Levit LA: Charting a new course for the delivery of high-quality cancer care. J Clin Oncol, 2013
19. Peppercorn JM, Smith TJ, Helft PR, et al: American Society of Clinical Oncology statement: Toward individualized care for patients with advanced cancer. J Clin Oncol 29:755-760, 2011
20. Weeks JC, Mack JW, Schrag D: Talking with patients about dying. N Engl J Med 368:480-481, 2013
21. Parker SM, Clayton JM, Hancock K, et al: A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: Patient/caregiver preferences for the content, style, and timing of information. J Pain Symptom Manage 34:81-93, 2007
22. Stacey D, Bennett CL, Barry MJ, et al: Decision aids for people facing health treatment or screening decisions. Cochrane Data Syst Rev 10:CD001431, 2011